PMID: 35149861 Nat Cancer. 2022 Mar;3(3):373.

Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.

Poll

1 of 4

NO change

BIG change

0% Article relates to my practice (0/0)

0% Article does not relate to my practice (0/0)

0% Undecided (0/0)

0% Yes (0/0)

0% No (0/0)

0% Undecided (0/0)

0% Yes (0/0)

0% No (0/0)

0% Undecided (0/0)

0% Level 1 (0/0)

0% Level 2 (0/0)

0% Level 3 (0/0)

0% Level 4 (0/0)

0% Level 5 (0/0)

Card

0 of 0

Action	Numeric Key	Letter Key	Function Key
Show Bullets		S	Enter (frontside only)
20%	1	N
40%	2	H
60%	3	F	Enter (backside only)
80%	4	E
100%	5	M
Previous Card			Left Arrow
Next Card		N	Right Arrow
Toss	0	T

Congratulations!
All cards in this set are done